Reduced Tumor Necrosis Factor  Production in Lipopolysaccharide-Treated Whole Blood From Patients in the Intensive Care Unit
John C. Setrakian, MD;
John Yee, MD;
Nicolas V. Christou, MD, PhD
Arch Surg. 1994;129(2):187-192.
Abstract
| |
Objective
To determine the cytokine response to lipopolysaccharide in patients in the intensive care unit.
Patients
Patients in a mixed medical/surgical intensive care unit with fever and a de novo clinical dysfunction of at least one organ system.
Methods
Whole blood from patients and from laboratory controls was stimulated with 8 ng/mL of lipopolysaccharide (Escherichia coli 0111:B4) at 37°C, and tumor necrosis factor  (TNF-) was measured using enzyme linked immunosorbent assay at 4,8, and 24 hours. The same subjects' purified monocytes were cultured with 8 ng/mL of lipopolysaccharide in the presence of autologous or pooled control plasma or cocultured with purified autologous polymorphonuclear leukocytes at a polymorphonuclear leukocyte—monocyte ratio of 10:1, and TNF- was measured at 24 hours using the enzyme linked immunosorbent assay.
Results
We detected high (n=5) and low (n=5) TNF- responders in whole blood producing a mean (±SEM) of 27.2± 6.3 pg/mL per 1000 monocytes vs 0.0±2.4 pg/mL per 1000 monocytes, respectively (controls, 58.0±13.0 pg/mL per 1000 monocytes). The kinetics of TNF- production in both groups were comparable. Purified monocytes from both groups of patients cultured with lipopolysaccharide alone produced equivalent TNF- values (42.4±10.5 vs 40.8± 12.5 pg/mL per 1000 monocytes). Assayable TNF- was not different with autologous vs control serum but was markedly diminished by the presence of polymorphonuclear leukocytes in patients as well as in controls; the two groups of patients did not differ in this polymorphonuclear leukocyte effect.
Conclusion
Lipopolysaccharide stimulation of monocytes in the whole blood results in marked variation of TNF- production. This phenomenon may account for the variable septic response to infection in patients in the intensive care unit.
(Arch Surg. 1994;129:187-192)
Author Affiliations
From the Departments of Surgery (Drs Setrakian, Yee, and Christou) and Microbiology and Immunology (Dr Christou), McGill University, Montreal, Quebec.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways
Sato et al.
Int Immunol 2002;14:783-791.
ABSTRACT
| FULL TEXT
Review: Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review
Cavaillon et al.
Innate Immunity 2001;7:85-93.
ABSTRACT
Effect of Ceftazidime on Systemic Cytokine Concentrations in Rats
Alkharfy et al.
Antimicrob. Agents Chemother. 2000;44:3217-3219.
ABSTRACT
| FULL TEXT
Hyporesponsiveness in leukocytes in sepsis: in vitro models reveal paradoxical effects of IL-10
Cavaillon et al.
Innate Immunity 1999;5:81-85.
ABSTRACT
Reduced Ex Vivo Interleukin-8 Production by Neutrophils in Septic and Nonseptic Systemic Inflammatory Response Syndrome
Marie et al.
Blood 1998;91:3439-3446.
ABSTRACT
| FULL TEXT
|
